nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000865	0.000865	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000864	0.000864	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000859	0.000859	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GNAS—polycystic ovary syndrome	0.000858	0.000858	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NPB—polycystic ovary syndrome	0.000856	0.000856	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—LEP—polycystic ovary syndrome	0.000854	0.000854	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000851	0.000851	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000848	0.000848	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000846	0.000846	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000841	0.000841	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—VEGFA—polycystic ovary syndrome	0.000839	0.000839	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP19A1—polycystic ovary syndrome	0.000831	0.000831	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000829	0.000829	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000824	0.000824	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SULT2A1—polycystic ovary syndrome	0.000822	0.000822	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00082	0.00082	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000819	0.000819	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000818	0.000818	CbGpPWpGaD
Sulpiride—CA6—Metabolism—NCOR1—polycystic ovary syndrome	0.000817	0.000817	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000816	0.000816	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00081	0.00081	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000803	0.000803	CbGpPWpGaD
Sulpiride—CA9—Metabolism—RRM2—polycystic ovary syndrome	0.000796	0.000796	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000795	0.000795	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00078	0.00078	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CYP1A1—polycystic ovary syndrome	0.000775	0.000775	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000774	0.000774	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00077	0.00077	CbGpPWpGaD
Sulpiride—CA9—Metabolism—YAP1—polycystic ovary syndrome	0.000767	0.000767	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000761	0.000761	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—LMNA—polycystic ovary syndrome	0.000759	0.000759	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000758	0.000758	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000758	0.000758	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PNPLA2—polycystic ovary syndrome	0.000753	0.000753	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000753	0.000753	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00075	0.00075	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000746	0.000746	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000744	0.000744	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—PPARG—polycystic ovary syndrome	0.000744	0.000744	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GNAS—polycystic ovary syndrome	0.000742	0.000742	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NAMPT—polycystic ovary syndrome	0.000737	0.000737	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	0.000728	0.000728	CbGpPWpGaD
Sulpiride—CA6—Metabolism—MTHFR—polycystic ovary syndrome	0.000722	0.000722	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000722	0.000722	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000715	0.000715	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000715	0.000715	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SRD5A1—polycystic ovary syndrome	0.000714	0.000714	CbGpPWpGaD
Sulpiride—CA12—Metabolism—NCOR1—polycystic ovary syndrome	0.000707	0.000707	CbGpPWpGaD
Sulpiride—CA2—Metabolism—TH—polycystic ovary syndrome	0.000695	0.000695	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000689	0.000689	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	0.000688	0.000688	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000682	0.000682	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—STAR—polycystic ovary syndrome	0.000681	0.000681	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000678	0.000678	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	0.000677	0.000677	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—GHRL—polycystic ovary syndrome	0.000677	0.000677	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000676	0.000676	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000674	0.000674	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000673	0.000673	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.00067	0.00067	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	0.00067	0.00067	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000669	0.000669	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000657	0.000657	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—ACE—polycystic ovary syndrome	0.000655	0.000655	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000655	0.000655	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000649	0.000649	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000649	0.000649	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000647	0.000647	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000636	0.000636	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000634	0.000634	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000631	0.000631	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—TCF7L2—polycystic ovary syndrome	0.00063	0.00063	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000628	0.000628	CbGpPWpGaD
Sulpiride—CA12—Metabolism—MTHFR—polycystic ovary syndrome	0.000625	0.000625	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00062	0.00062	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000615	0.000615	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000608	0.000608	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HMMR—polycystic ovary syndrome	0.000607	0.000607	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000597	0.000597	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000593	0.000593	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00059	0.00059	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PPARG—polycystic ovary syndrome	0.000586	0.000586	CbGpPWpGaD
Sulpiride—CA9—Metabolism—TH—polycystic ovary syndrome	0.000586	0.000586	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000582	0.000582	CbGpPWpGaD
Sulpiride—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	0.000581	0.000581	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00058	0.00058	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	0.000579	0.000579	CbGpPWpGaD
Sulpiride—CA6—Metabolism—POMC—polycystic ovary syndrome	0.000578	0.000578	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000576	0.000576	CbGpPWpGaD
Sulpiride—CA6—Metabolism—INS—polycystic ovary syndrome	0.000574	0.000574	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000574	0.000574	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000573	0.000573	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	0.00057	0.00057	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GNAS—polycystic ovary syndrome	0.000567	0.000567	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00056	0.00056	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000552	0.000552	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000547	0.000547	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000547	0.000547	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000543	0.000543	CbGpPWpGaD
Sulpiride—CA2—Metabolism—NCOR1—polycystic ovary syndrome	0.00054	0.00054	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	0.000536	0.000536	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—LHB—polycystic ovary syndrome	0.000528	0.000528	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000527	0.000527	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000523	0.000523	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	0.000516	0.000516	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000515	0.000515	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000512	0.000512	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000512	0.000512	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000512	0.000512	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000509	0.000509	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PPARG—polycystic ovary syndrome	0.000507	0.000507	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	0.0005	0.0005	CbGpPWpGaD
Sulpiride—CA12—Metabolism—POMC—polycystic ovary syndrome	0.0005	0.0005	CbGpPWpGaD
Sulpiride—CA12—Metabolism—INS—polycystic ovary syndrome	0.000497	0.000497	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000497	0.000497	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000492	0.000492	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000483	0.000483	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000478	0.000478	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GNAS—polycystic ovary syndrome	0.000478	0.000478	CbGpPWpGaD
Sulpiride—CA2—Metabolism—MTHFR—polycystic ovary syndrome	0.000478	0.000478	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000471	0.000471	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FST—polycystic ovary syndrome	0.000466	0.000466	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000464	0.000464	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000461	0.000461	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	0.00046	0.00046	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NCOR1—polycystic ovary syndrome	0.000455	0.000455	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000455	0.000455	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—RRM2—polycystic ovary syndrome	0.000446	0.000446	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000445	0.000445	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00044	0.00044	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	0.000432	0.000432	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000431	0.000431	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00043	0.00043	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—YAP1—polycystic ovary syndrome	0.00043	0.00043	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000429	0.000429	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000426	0.000426	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000421	0.000421	CbGpPWpGaD
Sulpiride—DRD3—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000417	0.000417	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	0.000413	0.000413	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00041	0.00041	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	0.000408	0.000408	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000407	0.000407	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000407	0.000407	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000405	0.000405	CbGpPWpGaD
Sulpiride—CA9—Metabolism—MTHFR—polycystic ovary syndrome	0.000403	0.000403	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.0004	0.0004	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.0004	0.0004	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000396	0.000396	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000392	0.000392	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00039	0.00039	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000389	0.000389	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PPARG—polycystic ovary syndrome	0.000387	0.000387	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	0.000385	0.000385	CbGpPWpGaD
Sulpiride—CA2—Metabolism—POMC—polycystic ovary syndrome	0.000382	0.000382	CbGpPWpGaD
Sulpiride—CA2—Metabolism—INS—polycystic ovary syndrome	0.00038	0.00038	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	0.000379	0.000379	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000376	0.000376	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00037	0.00037	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000366	0.000366	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000365	0.000365	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FST—polycystic ovary syndrome	0.000357	0.000357	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000355	0.000355	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000352	0.000352	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	0.00035	0.00035	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000349	0.000349	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000348	0.000348	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	0.000348	0.000348	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00034	0.00034	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000336	0.000336	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000332	0.000332	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00033	0.00033	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000329	0.000329	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TH—polycystic ovary syndrome	0.000328	0.000328	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000326	0.000326	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PPARG—polycystic ovary syndrome	0.000326	0.000326	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000326	0.000326	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000323	0.000323	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000322	0.000322	CbGpPWpGaD
Sulpiride—CA9—Metabolism—POMC—polycystic ovary syndrome	0.000322	0.000322	CbGpPWpGaD
Sulpiride—CA9—Metabolism—INS—polycystic ovary syndrome	0.00032	0.00032	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	0.000319	0.000319	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000319	0.000319	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000311	0.000311	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000306	0.000306	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000303	0.000303	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.0003	0.0003	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.0003	0.0003	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	0.0003	0.0003	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000299	0.000299	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000289	0.000289	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000287	0.000287	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000283	0.000283	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00028	0.00028	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000279	0.000279	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000278	0.000278	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GNAS—polycystic ovary syndrome	0.000268	0.000268	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000267	0.000267	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000265	0.000265	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000263	0.000263	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000262	0.000262	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	0.000255	0.000255	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000254	0.000254	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000253	0.000253	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00025	0.00025	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000249	0.000249	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000247	0.000247	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	0.000242	0.000242	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000231	0.000231	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00023	0.00023	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00023	0.00023	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	0.000225	0.000225	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000221	0.000221	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00022	0.00022	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000219	0.000219	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000216	0.000216	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000214	0.000214	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000213	0.000213	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000202	0.000202	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000201	0.000201	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000193	0.000193	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00019	0.00019	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000185	0.000185	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARG—polycystic ovary syndrome	0.000183	0.000183	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000181	0.000181	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—POMC—polycystic ovary syndrome	0.00018	0.00018	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—INS—polycystic ovary syndrome	0.000179	0.000179	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000176	0.000176	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000168	0.000168	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000165	0.000165	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000161	0.000161	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000155	0.000155	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INS—polycystic ovary syndrome	0.000154	0.000154	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000149	0.000149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000149	0.000149	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000142	0.000142	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000141	0.000141	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000138	0.000138	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000123	0.000123	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000119	0.000119	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INS—polycystic ovary syndrome	0.000118	0.000118	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000109	0.000109	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.76e-05	9.76e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6—polycystic ovary syndrome	8.74e-05	8.74e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.47e-05	7.47e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6—polycystic ovary syndrome	6.75e-05	6.75e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6—polycystic ovary syndrome	5.16e-05	5.16e-05	CbGpPWpGaD
